The novel picosecond lasers, initially developed for faster tattoo removal, have also shown great efficacy in endogenous pigmentary disorders. To describe the efficacy and safety profile of an alexandrite (755-nm) picosecond laser in a wide range of pigmented flat and elevated cutaneous lesions. A retrospective study was performed in which we collected all the clinical images of patients treated with the 755-nm alexandrite picosecond laser for 12 months (November 2016–November 2017). Clinical features were obtained from their medical charts. Patients treated for tattoo removal were excluded. All the images were analyzed by three blind physicians attending to a visual analogue scale (VAS) from 0 to 5 (0, no change; 1, 1–24% clearance; 2, 25–49% clearance; 3, 50–74% clearance; 4, 75–99% clearance; 5, complete clearance). Patient satisfaction was obtained from a subjective survey including four items: very satisfied, satisfied, non-satisfied, and totally dissatisfied. Thirty-seven patients were included (12 males; 25 females). The mean age of the study was 42.35 years. Twenty-five patients (68%) were treated for different pigmented flat disorders such as solar and mucosal lentigines (5), stasis dermatitis (4), or nevus of Ota (4), among other diagnoses. Twelve patients (32%) were treated for epidermal elevated lesions such as warts (5), epidermal nevi (2), and seborrheic keratosis (3), among other elevated lesions. Mean number of laser treatment was 3.02 sessions while mean follow-up after last laser treatment was 4.02 months. Mean VAS score of the three observers was 3.44 (61% of clearance) for pigmentary flat disorders and 3.60 (67%) for elevated lesions. Adverse effects reported were mild blistering in the first 2–5 days following laser treatment in some of the patients. Overall satisfaction among the patients included was high. The novel 755-nm picosecond alexandrite laser is effective not only for the resolution of pigmented flat lesions of different nature but also for the treatment of the more difficult elevated pigmented lesions.
Laser Picosecond laser Alexandrite laser Pigment laser Nevus of Ota Becker’s nevus
This is a preview of subscription content, log in to check access.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This study was properly approved by the institution of our Center.
Hexsel D, Hexsel C, Porto MD, Siega C (2015) Triple combination as adjuvant to cryotherapy in the treatment of solar lentigines: investigator-blinded, randomized clinical trial. J Eur Acad Dermatol Venereol 29:128–133CrossRefPubMedGoogle Scholar
Kunachak S, Kunachakr S, Sirikulchayanonta V, Leelaudomniti P (1996) Dermabrasion is an effective treatment for acquired bilateral nevus of Ota-like macules. Dermatol Surg 22:559–562PubMedGoogle Scholar
Anderson RR, Parrish JA (1983) Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 220:524–527CrossRefPubMedGoogle Scholar
Jun HJ, Cho SH, Lee JD, Kim HS (2014) A split-face, evaluator-blind randomized study on the early effects of Q-switched Nd:YAG laser plus Er:YAG micropeel (combined therapy) versus Q-switched Nd:YAG alone in light solar lentigines in Asians. Lasers Med Sci 29:1153–1158CrossRefPubMedGoogle Scholar
Wat H, Wu DC, Rao J, Goldman MP (2014) Application of intense pulsed light in the treatment of dermatologic disease: a systematic review. Dermatol Surg. 40:359–377CrossRefPubMedGoogle Scholar
Lorgeou A et al (2017) Comparison of two picosecond lasers to a nanosecond laser for treating tattoos: a prospective randomized study on 49 patients. J Eur Acad Dermatol Venereol. https://doi.org/10.1111/jdv.14492
Jakus J, Kailas A (2017) Picosecond lasers: a new and emerging therapy for skin of color, minocycline-induced pigmentation, and tattoo removal. J Clin Aesthet Dermatol 10:14–15PubMedPubMedCentralGoogle Scholar
Forbat E, Ali FR, Al-Niaimi F (2017) Applications of picosecond lasers beyond tattoos: pigment reduction and tissue remodeling. Lasers Med Sci 32:1219–1219CrossRefPubMedGoogle Scholar
Jerdan K, Hsu JT, Schnurstein E (2017) Successful treatment of Ota nevus with the 532-nm solid-state picosecond laser. Cutis 99:E29–E31PubMedGoogle Scholar
Friedmann DP, Buckley S, Mishra V (2017) Localized cutaneous argyria from a nasal piercing successfully treated with a picosecond 755-nm Q-switched alexandrite laser. Dermatol Surg. 43:1094–1095CrossRefPubMedGoogle Scholar
Vanaman Wilson MJ, Alkhonizi S, Wu DC (2017) Successful treatment of under-eye pigmentation in skin type IV with a picosecond alexandrite laser with diffractive lens array. Dermatol Surg 43:1095–1097CrossRefPubMedGoogle Scholar
Levin MK, Ng E, Bae Y-SC, Brauer JA, Geronemus RG (2016) Treatment of pigmentary disorders in patients with skin of color with a novel 755 nm picosecond, Q-switched ruby, and Q-switched Nd:YAG nanosecond lasers: a retrospective photographic review. Lasers Surg Med 48:181–187CrossRefPubMedGoogle Scholar
Ibrahimi OA, Sakamoto FH, Anderson RR (2013) Picosecond laser pulses for tattoo removal: a good, old idea. JAMA Dermatol 149:241CrossRefPubMedGoogle Scholar
Ho DD-M, London R, Zimmerman GB, Young DA (2002) Laser-tattoo removal—a study of the mechanism and the optimal treatment strategy via computer simulations. Lasers Surg Med 30:389–397CrossRefPubMedGoogle Scholar
Torbeck R, Bankowski R, Henize S, Saedi N (2016) Lasers in tattoo and pigmentation control: role of the PicoSure(®) laser system. Med Devices (Auckl) 9:63–67Google Scholar
Chan JC, Shek SY, Kono T, Yeung CK, Chan HH (2016) A retrospective analysis on the management of pigmented lesions using a picosecond 755-nm alexandrite laser in Asians. Lasers Surg Med 48:23–29CrossRefPubMedGoogle Scholar